By Fineline Cube China’s National Medical Products Administration (NMPA) released the Administrative Measures for Medical Device Online Sales (Revised Draft for Comments), a comprehensive overhaul of the existing 2017 framework that significantly tightens oversight of medical device e-commerce and introduces strict new requirements for livestream marketing.
Regulatory Framework Overview
| Item | Detail |
|---|---|
| Agency | National Medical Products Administration (NMPA) |
| Document | Administrative Measures for Medical Device Online Sales (Revised Draft for Comments) |
| Release Date | 24 Jul 2026 |
| Structure | Six chapters, 64 articles |
| Previous Version | 2017 regulations |
| Comment Period | Open for public feedback |
Key Provisions & Requirements
Operator Responsibilities
- Quality Management: Online sales operators and e-commerce platforms must establish and maintain robust quality management systems
- Traceability: All transaction information must be authentic and fully traceable throughout the supply chain
- Primary Liability: Clear delineation of primary responsibilities for both online sellers and platform operators
Livestream Marketing Restrictions
- Qualification Requirements: Livestream operators must possess legitimate medical device sales qualifications
- Personnel Rules: Livestream hosts must be direct employees of the selling enterprise
- Prohibited Items:
- All Class III medical devices banned from livestream sales
- Class II and Class I devices intended exclusively for medical institutions also prohibited
Platform Oversight Duties
- Qualification Verification: Platforms must rigorously review operator credentials upon onboarding
- Regular Updates: Verification updates required at minimum every six months
- Enforcement Actions: Mandatory implementation of warnings, transaction suspensions, and account cancellations for violations
- Blacklist System: Required establishment of comprehensive blacklist mechanisms
Compliance & Reporting Requirements
- Annual Self-Inspection: Platforms must submit detailed annual self-inspection reports to regulators
- Data Sharing: Encouragement of automated data-sharing mechanisms with regulatory authorities
- Legal Liabilities: Clear specification of legal responsibilities for both operators and platforms
- Penalty Structure: Violations subject to fines up to RMB 200,000 (approximately USD 28,000)
Market Impact Analysis
The proposed regulations represent a significant escalation in China’s regulatory approach to medical device e-commerce, particularly targeting the rapidly growing livestream commerce sector. By prohibiting high-risk medical devices from livestream sales and requiring strict qualification verification, the NMPA aims to balance innovation in digital healthcare distribution with patient safety concerns.
Industry stakeholders estimate that the new requirements could impact thousands of online medical device retailers and major e-commerce platforms, potentially reshaping business models that have relied heavily on livestream marketing for medical products. The emphasis on automated data sharing suggests a move toward real-time regulatory monitoring capabilities.
Forward‑Looking Statements
This brief contains forward-looking statements regarding regulatory developments. The draft measures are subject to public comment and may be modified before final implementation. Actual regulatory outcomes and market impacts may differ due to policy changes, industry feedback, and enforcement priorities.-Fineline Info & Tech